证券研究报告 2025年04月27日 行业报告 | 行业专题研究 分析师 陈金海 SAC执业证书编号：S1110521060001 联系人 李宁 请务必阅读正文之后的信息披露和免责申明 1 行业评级： 上次评级： 强于大市 强于大市 维持 （ 评级） 交通运输 摘要 交运平台高增长，进入利润兑现期 ⚫ 估值相对低位，发掘成长公司 作者： ⚫ 经营杠杆，利润进入兑现期 随着竞争格局稳定，销售、管理、研发费用维持稳定，毛利润增长有望带动营业利润更大 幅度增长。2024年满帮集团、美团、顺丰同城的营业利润成倍增长，未来或持续较快增长。 ⚫ 渗透率上升，毛利持续增长 网约车、网络货运、即时配送的渗透率上升，带动满帮集团、美团、顺丰同城等公司2024 年营收和毛利润30%左右增长。满帮集团的变现率上升，2024年毛利润增速42%。 风险提示：公路运价下跌风险，市场竞争加剧风险，监管要求降低佣金率风险 请务必阅读正文之后的信息披露和免责申明 2 1.1 聚焦交运高成长板块 高成长公司带来高回报机会。新兴的网约车、数字货运、即时配送等平台头部公司，业务 量和收入增速20%左右，营业利润成倍增长。随着新能源汽车普及、智能驾驶 ...

Core Viewpoint - The company, Yihe Jiaye, is a leading domestic manufacturer of non-invasive respiratory machines and ventilation masks, with significant growth in revenue and market share, particularly in the U.S. and European markets, following the end of the inventory clearance cycle in the U.S. respiratory machine market [1][5][7]. Company Overview - Established in 2001, the company has developed a comprehensive product line for respiratory health, including home non-invasive ventilators, masks, and monitoring devices, and has received multiple certifications such as NMPA, FDA, and CE [2]. - The company focuses on providing full-cycle treatment solutions for patients with OSA and COPD, covering diagnosis, treatment, and chronic disease management [2]. Research and Development - The company maintains a significant scale of R&D investment, holding 633 domestic patents and 202 international patents as of December 31, 2024, indicating a strong commitment to innovation [3]. Brand and Market Strategy - The company has unified its brand under "Ruimaite" to enhance user recognition and market penetration, planning to change its name and stock abbreviation to align with the new brand [4]. - The company aims to increase brand awareness through various channels, including exhibitions, academic exchanges, and social media marketing [4]. Market Conditions - The U.S. respiratory machine market has returned to normalcy after a period of inventory clearance, with the company’s products entering the market without significant impact from U.S.-China tariff policies [5][6]. - The company has achieved a high level of domestic supply chain security and cost advantages through the localization of core components [6]. Financial Performance - In Q4 2024, the company reported a 9.77% increase in revenue compared to Q3, driven by the recovery of the U.S. market [7]. - The overseas business generated 5.42 billion yuan, accounting for 64.21% of total revenue, while domestic revenue was 3.02 billion yuan, representing 35.79% [7]. Product Performance - The company’s home respiratory therapy business generated 5.27 billion yuan in revenue, while consumables contributed 2.84 billion yuan, with consumables showing a steady increase in proportion [7]. - Consumables saw a year-on-year growth of 46.22%, primarily driven by demand from the U.S. and European markets [8]. Market Share - According to data from Sullivan, the company held a 12.4% global market share for home non-invasive ventilators in 2023, ranking second, and a 30.6% share in the domestic market, ranking first among local brands [8].

【深圳商报讯】（记者肖晗）据港交所官信息，4月15日，深圳市顺友跨境物流股份有限公司（以下简 称"顺友物流"）递交招股书，拟在香港主板IPO上市。中信建投国际为其独家保荐人。 财务方面，公司在2022年、2023年、2024年分别实现收入11.84亿元、15.06亿元及15.22亿元人民币；同 期毛利率分别为6.2%、10.5%及6.7%，净利润为3187.5万元、7346.5万元、4387.5万元。 招股书显示，顺友物流成立于2008年，是资深跨境电商物流服务提供商。公司已于中国内地深圳、广 州、东莞、义乌、宁波、苏州，及中国香港和美国开展业务。公司向约220个国家及地区运送包裹，横 跨欧洲、北美洲、亚洲、南美洲、大洋洲及非洲六大洲，日均运送包裹量约为13万件。 （文章来源：深圳商报） 值得关注的是，招股书透露，公司已就应对美国关税变动采取了预设措施。公司已战略性推出新的物流 服务及海外仓服务，2024年分别实现收入2870万元和1010万元。美国市场并非公司主要战略重点，考虑 到美国针对中国电商公司政策所带来的不确定性，公司已自2024年下半年战略性缩减以美国为目的地的 直发物流服务。此外，不断扩大跨境物 ...